• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis.人外周血单个核细胞中的生物标志物:肌萎缩侧索硬化症的最新研究进展。
Int J Mol Sci. 2022 Feb 25;23(5):2580. doi: 10.3390/ijms23052580.
2
Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis.外周血单核细胞蛋白在肌萎缩侧索硬化症中的诊断和预后价值。
Neurobiol Dis. 2020 Jun;139:104815. doi: 10.1016/j.nbd.2020.104815. Epub 2020 Feb 20.
3
Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research.肌萎缩侧索硬化症患者外周血单个核细胞中线粒体功能、生物合成及降解的降低作为生物标志物研究的潜在工具
Mol Neurobiol. 2020 Dec;57(12):5084-5102. doi: 10.1007/s12035-020-02059-1. Epub 2020 Aug 25.
4
Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis.组织增强型血浆蛋白质组分析在肌萎缩侧索硬化症中的疾病分层。
Mol Neurodegener. 2018 Nov 7;13(1):60. doi: 10.1186/s13024-018-0292-2.
5
Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells.肌萎缩侧索硬化症外周血单个核细胞中的多种蛋白生物标志物。
PLoS One. 2011;6(10):e25545. doi: 10.1371/journal.pone.0025545. Epub 2011 Oct 5.
6
The Potential Connection between Molecular Changes and Biomarkers Related to ALS and the Development and Regeneration of CNS.分子变化与与 ALS 相关的生物标志物和中枢神经系统的发育和再生之间的潜在联系。
Int J Mol Sci. 2022 Sep 26;23(19):11360. doi: 10.3390/ijms231911360.
7
Fluid biomarkers for amyotrophic lateral sclerosis: a review.肌萎缩侧索硬化症的液体生物标志物:综述。
Mol Neurodegener. 2024 Jan 24;19(1):9. doi: 10.1186/s13024-023-00685-6.
8
RNA as a source of biomarkers for amyotrophic lateral sclerosis.RNA 作为肌萎缩侧索硬化症生物标志物的来源。
Metab Brain Dis. 2022 Aug;37(6):1697-1702. doi: 10.1007/s11011-021-00738-z. Epub 2021 Apr 27.
9
Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications.生物流体生物标志物在肌萎缩侧索硬化症中的预后价值:最新进展与治疗应用。
Cells. 2023 Apr 18;12(8):1180. doi: 10.3390/cells12081180.
10
Alteration of Motor Protein Expression Involved in Bidirectional Transport in Peripheral Blood Mononuclear Cells of Patients with Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症患者外周血单个核细胞中参与双向运输的运动蛋白表达的改变
Neurodegener Dis. 2016;16(3-4):235-44. doi: 10.1159/000443664. Epub 2016 Mar 9.

引用本文的文献

1
Impact of SOD1 Transcript Variants on Amyotrophic Lateral Sclerosis Severity.超氧化物歧化酶1(SOD1)转录变体对肌萎缩侧索硬化症严重程度的影响。
Int J Mol Sci. 2025 Jul 15;26(14):6788. doi: 10.3390/ijms26146788.
2
Biomarker Profile in Peripheral Blood Cells Related to Alzheimer's Disease.与阿尔茨海默病相关的外周血细胞生物标志物谱
Mol Neurobiol. 2025 Mar 10. doi: 10.1007/s12035-025-04767-y.
3
A mini review of leveraging biobanking in the identification of novel biomarkers in neurological disorders: insights from a rapid single-cell sequencing pipeline.利用生物样本库鉴定神经系统疾病新型生物标志物的小型综述:来自快速单细胞测序流程的见解
Front Neurosci. 2024 Dec 24;18:1473917. doi: 10.3389/fnins.2024.1473917. eCollection 2024.
4
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases.神经退行性疾病中氧化应激和炎症反应的新见解
Int J Mol Sci. 2024 Feb 26;25(5):2698. doi: 10.3390/ijms25052698.
5
Anti-inflammatory effects of L. extract on human peripheral blood mononuclear cells are mediated by TLR-4 and NF-κB suppression.L提取物对人外周血单个核细胞的抗炎作用是通过抑制TLR-4和NF-κB介导的。
Heliyon. 2024 Jan 4;10(1):e24040. doi: 10.1016/j.heliyon.2024.e24040. eCollection 2024 Jan 15.
6
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells.揭示肌萎缩侧索硬化症和帕金森病在外周血单核细胞中的共享和独特疾病途径。
ACS Chem Neurosci. 2023 Dec 6;14(23):4240-4251. doi: 10.1021/acschemneuro.3c00629. Epub 2023 Nov 8.
7
Proteomics Analysis of Lymphoblastoid Cell Lines from Patients with Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症患者淋巴母细胞系的蛋白质组学分析。
Molecules. 2023 Feb 21;28(5):2014. doi: 10.3390/molecules28052014.
8
Lysosomes Dysfunction Causes Mitophagy Impairment in PBMCs of Sporadic ALS Patients.溶酶体功能障碍导致散发性 ALS 患者 PBMCs 的线粒体自噬受损。
Cells. 2022 Apr 9;11(8):1272. doi: 10.3390/cells11081272.

本文引用的文献

1
RNA Molecular Signature Profiling in PBMCs of Sporadic ALS Patients: HSP70 Overexpression Is Associated with Nuclear SOD1.散发性 ALS 患者 PBMCs 中的 RNA 分子特征谱分析:HSP70 过表达与核 SOD1 相关。
Cells. 2022 Jan 15;11(2):293. doi: 10.3390/cells11020293.
2
Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis.蛋白质病作为肌萎缩侧索硬化症中基因表达受损、蛋白质稳态和线粒体功能障碍的标志
Front Neurosci. 2021 Dec 23;15:783624. doi: 10.3389/fnins.2021.783624. eCollection 2021.
3
DNA Damage and Repair Deficiency in ALS/FTD-Associated Neurodegeneration: From Molecular Mechanisms to Therapeutic Implication.肌萎缩侧索硬化症/额颞叶痴呆相关神经退行性变中的DNA损伤与修复缺陷:从分子机制到治疗意义
Front Mol Neurosci. 2021 Dec 16;14:784361. doi: 10.3389/fnmol.2021.784361. eCollection 2021.
4
MINCR: A long non-coding RNA shared between cancer and neurodegeneration.MINCR:一种在癌症和神经退行性疾病中共同存在的长链非编码RNA。
Genomics. 2021 Nov;113(6):4039-4051. doi: 10.1016/j.ygeno.2021.10.008. Epub 2021 Oct 15.
5
Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations.氧化应激作为肌萎缩侧索硬化症的治疗靶点:机遇与局限
Diagnostics (Basel). 2021 Aug 26;11(9):1546. doi: 10.3390/diagnostics11091546.
6
Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation.肌萎缩侧索硬化症患者表现出外周和鞘内T细胞活化增加。
Brain Commun. 2021 Jul 14;3(3):fcab157. doi: 10.1093/braincomms/fcab157. eCollection 2021.
7
Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.肌萎缩侧索硬化症和 SOD1 及 C9orf72 基因突变的估计患病率和发病率。
Neuroepidemiology. 2021;55(5):342-353. doi: 10.1159/000516752. Epub 2021 Jul 9.
8
The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS.氧化应激、氧化还原状态、生物能量学与线粒体在肌萎缩侧索硬化症病理生理学中的联系。
Int J Mol Sci. 2021 Jun 14;22(12):6352. doi: 10.3390/ijms22126352.
9
MicroRNAs Instruct and Maintain Cell Type Diversity in the Nervous System.微小RNA指导并维持神经系统中的细胞类型多样性。
Front Mol Neurosci. 2021 Apr 29;14:646072. doi: 10.3389/fnmol.2021.646072. eCollection 2021.
10
Combined epigenetic/genetic study identified an ALS age of onset modifier.联合表观遗传学/遗传学研究鉴定出 ALS 发病年龄的修饰物。
Acta Neuropathol Commun. 2021 Apr 23;9(1):75. doi: 10.1186/s40478-021-01183-w.

人外周血单个核细胞中的生物标志物:肌萎缩侧索硬化症的最新研究进展。

Biomarkers in Human Peripheral Blood Mononuclear Cells: The State of the Art in Amyotrophic Lateral Sclerosis.

机构信息

IRCCS Mondino Foundation, 27100 Pavia, Italy.

Department of Brain and Behavioral Sciences, University of Pavia, Via Forlanini 6, 27100 Pavia, Italy.

出版信息

Int J Mol Sci. 2022 Feb 25;23(5):2580. doi: 10.3390/ijms23052580.

DOI:10.3390/ijms23052580
PMID:35269723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8910056/
Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by the progressive loss of lower motor neurons, weakness and muscle atrophy. ALS lacks an effective cure and diagnosis is often made by exclusion. Thus, it is imperative to search for biomarkers. Biomarkers can help in understanding ALS pathomechanisms, identification of targets for treatment and development of effective therapies. Peripheral blood mononuclear cells (PBMCs) represent a valid source for biomarkers compared to cerebrospinal fluid, as they are simple to collect, and to plasma, because of the possibility of detecting lower expressed proteins. They are a reliable model for patients' stratification. This review provides an overview on PBMCs as a potential source of biomarkers in ALS. We focused on altered RNA metabolism (coding/non-coding RNA), including RNA processing, mRNA stabilization, transport and translation regulation. We addressed protein abnormalities (aggregation, misfolding and modifications); specifically, we highlighted that SOD1 appears to be the most characterizing protein in ALS. Finally, we emphasized the correlation between biological parameters and disease phenotypes, as regards prognosis, severity and clinical features. In conclusion, even though further studies are needed to standardize the use of PBMCs as a tool for biomarker investigation, they represent a promising approach in ALS research.

摘要

肌萎缩侧索硬化症(ALS)是一种毁灭性的神经退行性疾病,其特征是下运动神经元逐渐丧失、肌肉无力和萎缩。ALS 缺乏有效的治疗方法,通常通过排除法进行诊断。因此,寻找生物标志物至关重要。生物标志物可以帮助我们理解 ALS 的发病机制、确定治疗靶点并开发有效的治疗方法。与脑脊液相比,外周血单核细胞(PBMCs)作为生物标志物的来源更为可靠,因为其易于采集,而且与血浆相比,更有可能检测到低表达蛋白。它们是患者分层的可靠模型。本综述概述了 PBMCs 作为 ALS 生物标志物的潜在来源。我们重点介绍了改变的 RNA 代谢(编码/非编码 RNA),包括 RNA 加工、mRNA 稳定性、运输和翻译调控。我们还讨论了蛋白质异常(聚集、错误折叠和修饰);具体而言,我们强调了 SOD1 似乎是 ALS 中最具特征性的蛋白质。最后,我们强调了生物学参数与疾病表型之间的相关性,包括预后、严重程度和临床特征。总之,尽管需要进一步的研究来标准化 PBMCs 作为生物标志物研究工具的使用,但它们是 ALS 研究中很有前途的方法。